Perkins Capital Management Inc Fortress Biotech, Inc. Transaction History

Perkins Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.65 - $1.1 $387,725 - $656,150	596,500 Added 72.52%	1,419,013 $1.16 Million
Q4 2022 Jan 26, 2023	BUY	$0.48 - $0.88 $14,400 - $26,400	30,000 Added 3.79%	822,513 $539,000
Q3 2022 Oct 24, 2022	BUY	$0.79 - $22.0 $24,901 - $693,462	31,521 Added 4.14%	792,513 $682,000
Q2 2022 Jul 29, 2022	BUY	$0.8 - $1.5 $526,549 - $987,280	658,187 Added 640.23%	760,992 $639,000
Q4 2021 Feb 10, 2022	SELL	$2.42 - $3.65 $62,920 - $94,900	-26,000 Reduced 20.19%	102,805 $257,000

Q2 2021 Jul 28, 2021	BUY	$3.5 - $5.48 $5,162 - $8,083	1,475 Added 1.16%	128,805 $460,000
Q1 2021 Apr 28, 2021	BUY	$3.16 - $4.89 $402,362 - $622,643	127,330 New	127,330 $449,000

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Perkins Capital Management Inc with notifications on news.